Abstract:Abstract Solid-organ transplant recipients (SOTRs) have a significantly increased risk of developing skin cancer, with approximately 50% in some populations developing one or more in their lifetime. Many international guidelines recommend at least annual review for all SOTRs regardless of risk status, with significant implications for healthcare resources. In the UK, guidance from the National Institute for Health and Care Excellence (NICE) recommends surveillance in dedicated clinics, although specific guidance on the structure of such clinics, risk stratification and surveillance protocols is not provided. Despite NICE recommendations, there is currently variable service provision for SOTRs across the country. This is due, at least in part, to the lack of commissioning for specialist SOTR skin cancer surveillance clinics and restricted access to surveillance in transplant centres in more rural areas (Cordaro A, Dobbs TD, Gibson JAG et al. Skin cancer screening in organ transplant centres in the United Kingdom: a national survey. Eur J Dermatol 2020; 30: 372–6). The aim of this study is to develop a national consensus statement providing practical, evidence-based guidance for delivery of safe, high-quality skin cancer surveillance services that could be implemented equitably across the UK. To address this, an expert national working group has been established by the British Society for Skin Care in Immunosuppressed Individuals (BSSCII) and includes dermatologists, transplant physicians, clinical nurse specialists, allied health professionals and patient representatives. An initial comprehensive literature review has been undertaken to inform the evidence base for developing this consensus statement and has included studies based on case series of at least 20 patients using a range of data sources (PubMed, National Institute for Health and Care Research, Cochrane Library, Embase, NICE Evidence Search). A process of subsequent consensus meetings will establish final recommendations with a plan to use these for future service commissioning. Here, we discuss the primary recommendations from this study in relation to skin cancer surveillance service delivery. These include timing of the initial dermatology review, frequency of follow-up, location of review (local vs. specialist dermatology departments) and patient stratification according to risk, including use of risk assessment tools. Outcome measures of interest include rates of skin cancer diagnoses and of precancerous skin lesions, adherence to self-monitoring and sun protection advice and patient satisfaction. In summary, we highlight the wide discrepancy in skin cancer surveillance provision for SOTRs across the UK. We present the steps taken by a BSSCII working group to formulate a consensus statement to guide the delivery of skin cancer surveillance services. This consensus statement will be used as the basis for formal specialist commissioning with the ultimate aim of securing funding for SOTR skin cancer surveillance clinics nationwide.

Evolution of skin cancer numbers in solid organ transplant recipients: a pilot study

Treatment of skin cancers in solid organ transplant recipients: current status and future perspectives

BI09 Skin cancer burden and dermatological follow-up in solid-organ transplant recipients: a regional study

Skin cancer in renal transplant recipients: outcomes from a safety net hospital in Boston

Update on skin cancer prevention modalities and screening protocols in solid organ transplant recipients: a scoping review

Interventions to Prevent Nonmelanoma Skin Cancers in Recipients of a Solid Organ Transplant: Systematic Review of Randomized Controlled Trials

Skin cancer in organ transplant recipients: dynamics in the incidence and clinical predictors for the first and subsequent post‐transplant non‐melanoma skin cancer

Early Results of a Screening Program for Skin Cancer in Liver Transplant Recipients: A Cohort Study

Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines

Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland

Photodynamic therapy: A targeted literature review focussing on outcomes and optimisation in solid organ transplant recipients

Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients

Cutaneous Squamous Cell Carcinoma Outcomes in Solid Organ Transplant Recipients: A Matched Retrospective Cohort Study

Cumulative incidence and risk factors for cutaneous squamous-cell carcinoma metastases in organ transplant recipients: the SCOPE-ITSCC metastases study, a prospective multi-center study.

A case controlled study of risk factors for metastatic squamous cell carcinoma in organ transplant recipients: single academic medical center

Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients

Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta‐analysis

Analysis of Clinicopathological Features of Papillary Thyroid Carcinoma in Solid Organ Transplant Recipients: a Retrospective Study

BI08 Delivery of stratified skin cancer surveillance in solid-organ transplant recipients: development of a consensus statement on behalf of the British Society for Skin Care in Immunosuppressed Individuals

Diagnosis and Treatment of Skin Lesions in Renal Transplant Recipients: A Retrospective Review

Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma